|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatic stellate cells:it's role in normal and pathological conditions显示文摘 | Sarem M Znaidak R Macías M | 2006 | Gastroenterol Hepatol2006，29，2： | 1 |
| 2 | Hepatic stellate cells:it's role in noruud and patholngical conditions显示文摘 | Sarem M Znaidak R Macías M | 2006 | Gastrcenterologíay hepatolngía2006，29，： | 1 |
| 3 | SLA negotiation and enforcement policies for revenue maximization and client classification in cloud providers 显示文摘 | MACíAS M GUITART J | 2014 | Future generation computer systems2014，41，： | 1 |
| 4 | Bioactive steroids and triterpenes from Melilotusmessanensisand their allelopathic potential显示文摘 | Macías F A Simonet A M Galindo J C | | 0，，07： | 1 |
| 5 | Bioactive phenolics and polar compounds from Melilotusmessanensis显示文摘 | Macías F A Simonet A M Galindo J C | | 0，，01： | 1 |
| 6 | Novel bioactive breviane spiroditerpenoids from Penicillium brevicompactum Dierkx显示文摘 | Macías F A Varela R M Simonet A M | 2000 | Org Chem2000，65，26： | 1 |
| 7 | Allelopathy - a natural alternative for weed control显示文摘 | MACíAS F A MOLINILLO J M G VARELA R M | 2007 | Pest Management Science2007，63，4： | 1 |
| 8 | Immobilization ofglucose oxidase within calcium alginate gel capsules显示文摘 | Blandino A Macías M Cantero D | 2001 | Process Biochemistry2001，36，7： | 1 |
| 9 | Melatonin but not vitamins C and E maintains glutathione homeo-stasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress显示文摘 | Martín M Macías M Escames G León J Acu?a-Castroviejo D | | 0，，： | 1 |
| 10 | Ultrasonography in patients with chronic liver disease:its usefulness in the diagnosis of cirrhosis显示文摘 | Macías Rodríguez M A Rendón Unceta P Navas Relinque C | | 0，，4： | 1 |
| 11 | Allelopathic agents from aquatic ecosystems:potential biopesticides models显示文摘 | Macías F A Galindo J L G García-Díaz M D | 2008 | Phytochemistry Reviews2008，7，1： | 1 |
| 12 | Use of colonoscopy as a primary screening test for colorectal cancer in average risk people显示文摘 | Betés M Mu(n)oz-Navas M A Duque J M Angǒs R Macías E Súbtil J C | | 0，，： | 1 |
| 13 | Evolution of costs of cancer drugs in a Portuguese hospital显示文摘AIM:To analyze the costs of cancer drugs administered in a Portuguese Hospital compared with the Karolinska Institute study.METHODS:To evaluate spending on cancer drugs, we retrospectively analyzed data on the overall costs of cancer drugs, obtained at the Department of Medical Oncology of the Centro Hospitalar de Entre Douro e Vouga, between 2004 and 2010. In this comparative study we selected only drugs belonging to the following groups:chemotherapy, targeted therapy, immunotherapy and endocrine therapy. The selected drugs were further grouped according to their market placement year:≤ 1998, 1999 to 2002, 2003 to 2005, and 2006 to 2010. Drugs used as supportive therapy and bisphosphonates were excluded.RESULTS:The overall costs of cancer drugs increased gradually between 2004 and 2008(from €1911947 to €3666284), with an increase in the number of patients treated during this period. The expenditure decreased in 2009(€3438155) and increased again in 2010(€3673116), but the costs increment was not the same as in previous years. Chemotherapy and targeted therapy were responsible for most of the expenditure. Drugs placed on the national market before 1999 accounted for more than 50% of the expenditure up to 2007. From 2008, these drugs represented less than 50% of the total expenditure. Cancer drugs placed between 1999 and 2002 accounted for 25%-35% of the costs in all the years studied, while drugs placed between 2003 and 2005 accounted for less than 30%. Drugs placed between 2006 and 2010 were responsible for less than 10% of the expenditure.CONCLUSION:In this study, older drugs were responsible for most of the expenditure up to 2007, which is in agreement with the Karolinska study. | Vania Peixoto Ana Luísa Faria Márcia Gon?alves Joana Macedo Sónia Rego Emilio Macías Aldiro Magano Márcia Loureiro António Araújo | 2014 | World Journal of Clinical Oncology2014，5，2： | 0 |
| 14 | Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy显示文摘 | Juan Macías Manuel Márquez Francisco Téllez Dolores Merino Patricia Jiménez-Aguilar Luis F. López-Cortés Enrique Ortega Miguel A. von Wichmann Antonio Rivero María Mancebo Jesús Santos Montserrat Pérez-Pérez Ignacio Suárez-Lozano Alberto Romero-Palacios A | 2013 | Clinical Infectious Diseases2013，，10： | 1 |
| 15 | Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis显示文摘 | Nicolás Merchante Antonio Rivero‐Juárez Francisco Téllez Dolores Merino Maria José Ríos‐Villegas Manuel Márquez‐Solero Mohamed Omar Juan Macías ángela Camacho Montserrat Pérez‐Pérez Jesús Gómez‐Mateos Antonio Rivero Juan Antonio Pineda | 2012 | Hepatology2012，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员